Results 151 to 160 of about 29,348 (182)
Some of the next articles are maybe not open access.
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Gene regulation of muscarinic receptor subtypes
2001Of the five cloned muscarinic receptor subtypes, human airways express only three receptor subtypes (M1, M2 and M3) and these subtypes are differentially distributed in the airways [1]. M1-receptors are localised to alveolar walls, parasympathetic ganglia and submucosal glands, whereas M3-receptors are predominant in airway smooth muscle and submucosal
openaire +1 more source
Muscarinic receptor subtypes and smooth muscle function
Pharmacological Reviews, 1996R M, Eglen, S S, Hegde, N, Watson
openaire +2 more sources
CORTICAL MUSCARINIC RECEPTOR SUBTYPES AND ALZHEIMER'S DISEASE
The Lancet, 1982M P, Caulfield +4 more
openaire +2 more sources
A review of cancer immunotherapy toxicity
Ca-A Cancer Journal for Clinicians, 2020Lucy Boyce Kennedy
exaly
Treatment of muscle‐invasive and advanced bladder cancer in 2020
Ca-A Cancer Journal for Clinicians, 2020Vaibhav G Patel +2 more
exaly
New subtypes of muscarinic acetylcholine receptors.
Trends in pharmacological sciences, 1990Human and rat genes and/or cDNAs for five different mAChRs have been cloned. The m1, m2 and m3 receptors correspond most closely to the pharmacologically defined M1, M2 and M3 receptors and are expressed in both brain and peripheral tissues. The m4 and m5 receptors are previously unrecognized pharmacological subtypes whose mRNAs are found predominantly
openaire +1 more source
Breast cancer statistics, 2019
Ca-A Cancer Journal for Clinicians, 2019Carol E Desantis, Jiemin, Mia M Gaudet
exaly